Publication details
Zpráva o průběhu klinického hodnocení KDO_DC1311 Annual Report za období 10. září 2020 ‒ 9. září 2021
| Title in English | KDO_DC1311 Clinical trial Annual Report for the period September 10, 2020 - September 9, 2021 |
|---|---|
| Authors | |
| Year of publication | 2021 |
| MU Faculty or unit | |
| Web | KDO_DC1311 |
| Description | Combination antitumor therapy with ex vivo manipulated interleukin-12-producing dendritic cells in pediatric, adolescent, and young adult patients with high-risk progressive, relapsed, or primarily metastatic malignancies, protocol number KDO_DC1311. |
| Related projects: |